Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla

Brain Research

Volumn 779, Issue 1-2, 1998, Pages 104-118

  Helmstetter, Fred J ^a   Tershner, Sheralee A ^a   Poore, Laura H ^a   Bellgowan, Patrick S F ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Amygdala; Anesthesia; Antinociception; Heart rate; Opioid; Pain; Periaqueductal gray; Rat; Rostral medulla; Tail flick

Indexed keywords

BARBITURIC ACID DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; LIDOCAINE; OPIATE; SIGMA OPIATE RECEPTOR;

AMYGDALOID NUCLEUS; ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ATTENUATION; CONTROLLED STUDY; HEART RATE; HYPOALGESIA; MALE; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

AMYGDALA; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; LIDOCAINE; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; PAIN; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RECEPTORS, OPIOID, MU; REFLEX; STIMULATION, CHEMICAL;

EID: 0031975934     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01104-9     Document Type: Article

References (35)

1. al-Rodhan N., Chipkin R., Yaksh T.L. The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala. Brain Res. 520:1990;123-130.
2. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Ann. Rev. Neurosci. 7:1984;38-309.
3. Carstens E., Douglas D.K. Midbrain suppression of limb withdrawal and tail flick reflexes in the rat: correlates with descending inhibition of sacral spinal neurons. J. Neurophys. 73:1995;2179-2194.
4. Carstens E., Wilson C. Rat tail flick reflex: magnitiude measurement of stimulus-reponse function, suppression by morphine and habituation. J. Neurophys. 70:1993;630-639.
5. J. de Olmos, G.F. Alheid, C.A. Beltramino, Amygdala, in: G. Paxinos (Ed.), The Rat Nervous System: I. Forebrain and Midbrain, Academic Press, New York, 1985.
6. Da Costa Gomez T.M., Behbehani M.M. An electrophysiological characterization of the projection from the central nucleus of the amygdala to the periaqueductal gray of the rat: the role of opioid receptors. Brain Res. 689:1995;21-31.
7. Fields H.L., Heinricher M.M. Brainstem modulation of nociceptor-driven withdrawal reflexes. Ann. NYAS. 563:1989;34-44.
8. Fields H.L., Heinricher M.M., Mason P. Neurotransmitters in nociceptive modulatory circuits. Ann. Rev. Neurosci. 14:1991;219-246.
9. W.L. Hays, Statistics, 3rd edn., Holt, Rinehart & Winston, New York, 1981.
10. Helmstetter F.J., Bellgowan P.S.F., Poore L.H. Microinfusion of mu, but not delta or kappa opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats. J. Pharm. Exp. Ther. 275:1995;381-388.
11. Helmstetter F.J., Tershner S.A. Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses. J. Neurosci. 14:1994;7099-7108.
12. Helmstetter F.J., Bellgowan P.S. Lesions of the amygdala block conditional hypoalgesia on the tail flick test. Brain Res. 612:1993;253-257.
13. Helmstetter F.J., Bellgowan P.S., Tershner S.A. Modulation of spinal nociceptive reflexes by the microinjection of morphine into the amygdala. NeuroReport. 4:1993;471-474.
14. Helmstetter F.J. The amygdala is critical for the expression of conditional hypoalgesia. Behav. Neurosci. 106:1992;518-528.
15. Kalivas P.W., Gau B.A., Nemeroff C.B., Prange A.J. Antinociception after microinjection of neurotensin into the central amygdaloid nucleus of the rat. Brain Res. 243:1982;279-286.
16. Kim J.J., Rison R.A., Fanselow M.S. Effects of amygdala, hippocampus and periaqueductal gray lesions on short- and long-term contextual fear. Behav. Neurosci. 107:1993;1093-1098.
17. Klamt J.G., Prado W.A. Antinociception and behavioral changes induced by carbachol microinjected into identified sites of the rat brain. Brain Res. 549:1991;9-15.
18. T.A. Lovick, Interactions between descending pathways from the dorsal and ventrolateral periaqueductal gray matter in the rat, in: A. Depaulis, R. Bandler (Eds.), The Midbrain Periaqueductal Gray Matter: Functional, Anatomical and Neurochemical Organization, Plenum, New York, 1991, pp. 101-120.
19. Lovick T.A. Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal gray matter in rats. Pain. 21:1985;241-252.
20. Ma Q.P., Han J.S. Naloxone blocks the release of opioid peptides in periaqueductal gray and N. accumbens induced by intra-amygdaloid injection of morphine. Peptides. 12:1991;1235-1238.
21. Ma Q.P., Han J.S. Neurochemical studies on the mesolimbic circuitry of antinociception. Brain Res. 566:1991;95-102.
22. Manning B.H., Mayer D.J. The central nucleus of the amygdala contributes to the production of morphine analgesia on the formalin test. Pain. 63:1995;141-152.
23. Martin J.H. Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat. Neurosci. Lett. 127:1991;160-164.
24. Oliveira M.A., Prado W.A. Antinociception and behavioral manifestations induced by intracerebroventricular or intra-amygdaloid administration of cholinergic agonists in the rat. Pain. 57:1994;383-391.
25. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
26. Poore L.H., Helmstetter F.J. Mu opioids in the RVM contribute to antinociception following DAMGO stimulation of the amygdala. Soc. Neurosci. Abstr. 22:1996;116.
27. Proudfit H.K. Reversible inactivation of raphe magnus neurons: effects on nociceptive threshold and morphine analgesia. Brain Res. 201:1980;459-464.
28. Rosenfeld J.P., Xia L.Y. Reversible tetracaine block of rat periaqueductal gray (PAG) decreases baseline tail-flick latency and prevents analgesic effects of met-enkephalin injections in the nulceus paragigantocelluarlis (PGC). Brain Res. 605:1993;57-66.
29. Sandkuhler J., Gebhart G.F. Relative contributions of the nucleus raphe magnus and adjacent medullary reticular formation to the inhibition by stimulation in the periaqueductal gray of a spinal nociceptive reflex in the pentobarbital-anesthetized rat. Brain Res. 305:1984;77-87.
30. Sandkuhler J., Maisch B., Zimmermann M. The use of local anesthetic microinjections to identify central pathways: a quantitative evaluation of the time course and extent of the neuronal block. Exp. Brain Res. 68:1987;168-178.
31. M.T. Shipley, M. Ennis, T.A. Rizvi, M. Behbehani, Topographical specificity of forebrain inputs to the midbrain periaqueductal gray: evidence for discrete longitudinally organized input columns, in: A. Depaulis, R. Bandler (Eds.), The Midbrain Periaqueductal Gray Matter, Plenum, New York, 1991.
32. Stornetta R.L., Morrison S.F., Ruggiero D.A., Reis D.J. Neurons of rostral ventrolateral medulla mediate somatic pressor reflex. Am. J. Physiol. 256:1989;R448-R462.
33. Tershner S.A., Helmstetter F.J. Spinal antinociception following stimulation of the amygdala depends on opioid receptors in the ventral periaqueductal gray. Soc. Neurosci. Abstr. 21:1995;1169.
34. Thurston C.L., Randich A. Responses of on and off cells in the rostral ventral medulla to stimulation of vagal afferents and changes in mean arterial blood pressure in intact and cardiopulmonary deafferented rats. Pain. 62:1995;19-38.
35. Watkins L.R., Cobelli D.A., Mayer D.J. Classical conditioning of front paw and hind paw footshock induced analgesia (FSIA): naloxone reversibility and descending pathways. Brain Res. 243:1982;119-132.